ResMed Story

ResMed Inc -- USA Stock  

USD 88.73  0.87  0.99%

Macroaxis does not monitor all media channels or aggregates social signals for ResMed. But even though we do not provide professional-grade financial sentiment analysis on ResMed Inc, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for ResMed. Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance
Payment of 4027 shares by Don Darkin of ResMed subject to Rule 16b-3
Filed transaction by Resmed Inc officer. Payment of exercise price or tax liability by delivering or withholding securities

ResMed Inc insider trading alert for payment of resmed common stock by Don Darkin, Pres. SDB SBU, on January 3, 2018. This event was filed by Resmed Inc with SEC on 2012-11-13. SEC Form: Changes in beneficial ownership. Don Darkin is currently serves as president - sleep-disordered breathing strategic business unit of ResMed Inc

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This article from MacroaxisInsider published on 03 of January contributed to the next trading period price escalation.The trading delta at closing time to the next next day price was 0.14% . The trading delta at closing time when the story was published to current price is 2.14% .

Similar stores for ResMed

a day ago at www.macroaxis.com 
Exercise or conversion by Rich Sulpizio of 12000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
few days ago at http://finnewsweek.com 
RMI Signaling Increased Momentum For Resmed Inc
news
Investors and paying cloes attention to shares of Resmed Inc as the Relative Momentum Indicator or RMI has been spotted trending higher over the past week.
over a week ago at www.macroaxis.com 
Exercise or conversion by Michael Farrell of 30000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Did you try this?

Run Portfolio Center Now
   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
Hide  View All  NextLaunch Portfolio Center

Profit Margin

Profit Margin Comparative Analysis
  Profit Margin 
      ResMed Comparables 
ResMed is rated second in profit margin category among related companies. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.